Experimental drug combo offers hope for Tough-to-Treat lung cancer
NCT ID NCT06931626
Summary
This early-stage study is testing a new drug called NMS-03305293 combined with an existing chemotherapy drug (temozolomide) for people with small cell lung cancer that has returned after previous treatments. The main goal is to check if this combination is safe and tolerable for patients. Researchers will also look for signs that the treatment might help shrink tumors and measure how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Tennessee Oncology, PLLC
RECRUITINGNashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.